Hays Pharma
Hays Pharma, a prominent player in the pharmaceutical industry, is headquartered in France and operates extensively across Europe and beyond. Founded in the early 2000s, the company has established itself as a leader in providing innovative healthcare solutions, focusing on areas such as prescription medications, over-the-counter products, and specialised therapies. With a commitment to quality and efficacy, Hays Pharma's core offerings include a diverse range of pharmaceuticals that cater to various medical needs. The company is recognised for its unique approach to drug development, emphasising research and collaboration to deliver effective treatments. Hays Pharma has achieved significant milestones, positioning itself as a trusted name in the market, known for its dedication to improving patient outcomes and advancing healthcare standards.
DitchCarbon Score
How does Hays Pharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Hays Pharma's score of 6 is higher than 71% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Hays Pharma's reported carbon emissions
Hays Pharma, headquartered in France, currently does not have available data on its carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This absence of data suggests that Hays Pharma may still be in the early stages of formalising its climate commitments or reporting on its carbon footprint. As the pharmaceutical industry increasingly prioritises sustainability, it is essential for companies like Hays Pharma to establish clear emissions reduction strategies and set measurable targets to align with global climate goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Hays Pharma is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
